Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with a
survival prognosis of 14-16 mo for the highest functioning patients. Despite aggressive …

Purpose: The “InCise™ multileaf‐collimator (MLC)” is the first commercial MLC to be
mounted on a robotic SRS/SBRT platform (CyberKnife). The authors assessed …

Stereotactic radiosurgery (SRS) has proven to be an effective strategy in the management of
intracranial arteriovenous malformations (AVMs) in children and adults over the past three …

Stereotactic radiosurgery with an adapted linear accelerator (linac-SRS) is an established
therapy option for brain metastases, benign brain tumors, and arteriovenous malformations …

Background Few dosimetric comparisons have been published between linear accelerator
(LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac …

Purpose: To investigate the dosimetric comparison of different collimators which are used in
robotic radiosurgery (cyberknife-CK) and linear accelerator (LINAC) for stereotactic …

Background: Several high-precision stereotactic radiation therapy modalities are currently
used in clinical settings. We aimed to evaluate whether the CyberKnife (CK) or TrueBeam …

It was aimed to investigate the dosimetric differences among linac-based and robotic
stereotactic radiotherapy (SRT) techniques for the treatment of uveal melanoma and to …

Background: Stereotactic radiotherapy (SRT) for patients with intracranial tumours are
delivered using a dedicated platform or a conventional linear accelerator with a flattening …

Results: In the first follow-up evaluation (mean 4.5 months after the treatment), pain was
stable in 5 of 8 evaluable cases and in 3 regression occurred. The last follow-up …